The Dow Chemical Company
Dow Chemical Commits $5 Million to Hamner Institutes for Health Sciences for Chemical Safety Initiatives
Published in Drug Law Weekly, April 20th, 2010
The Dow Chemical Company (NYSE: DOW) and The Hamner Institutes for Health Sciences together announce that Dow will contribute $5 million over five years to The Hamner Institutes to support chemical safety through the development of new computational models of toxicity. This contribution is part of Dow's focus on product safety leadership and the advancement of science to support risk-based chemical safety assessments - key tenets of Dow's sustainability commitments as a world leader in chemistry.
The Hamner Program in Chemical Safety Sciences will leverage funding provided by Dow and other industry partners, along with funding from the American Chemistry Council - for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2010-04-20)
More Articles from Drug Law Weekly
- Academy of Managed Care Pharmacy AMCP
AMCP, FMCP Confer Awards for Distinguished Service, AMCP Fellow, Steve G. Avey and JMCP Excellence - Addiction Medicine
Research from A.S. Unger and co-researchers yields new findings on addiction medicine - Aetna
Aetna Statement Regarding CMS Actions - AmeriLithium Corp.
AmeriLithium's Australia Project Situated to Exploit China's Market - Angiotech Pharmaceuticals, Inc.
Angiotech closes acquisition of certain product candidates and technology assets of Haemacure Corporation - China Yongxin Pharmaceuticals, Inc.
China Yongxin Pharmaceuticals Reports a 26% Increase in net Income for the 2009 Fiscal Year - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
